全球廠商中立歸檔（VNA）市場：依部署方式、廠商類型、醫學影像類型、最終使用者和地區分類

Global Vendor Neutral Archive (VNA) Market, By Deployment Model, By Vendor Type, By Imaging Type, By End User, By Geography

出版日期: 2026年04月27日 | 出版商:

Coherent Market Insights | 英文 250+ Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

全球廠商中立歸檔（VNA）市場預計到 2026 年將達到 41.8 億美元，預計到 2033 年將達到 61.2 億美元。預計從 2026 年到 2033 年，其複合年成長率將達到 5.6%。

分析範圍		分析詳情
基準年	2025	市場規模（2026 年）	41.8億美元
效能數據	2020-2024	預測期	2026-2033
預測期（2026-2033 年）複合年成長率	5.60%	預計金額（2033 年）	61.2億美元

廠商中立歸檔系統 (VNA) 是一種影像管理解決方案，它支援儲存、搜尋和存取來自多種來源和模式的醫學影像及相關報告，並可應用於所有醫療應用。傳統上，醫療機構需要管理多個 PACS 系統來儲存和存取放射影像，這導致成本增加和技術複雜性上升。 VNA 提供了一個中央儲存庫，將來自所有科室、來源和專業的影像資料整合到一個統一的歸檔系統中。這有助於提高互通性、實現普遍存取並最佳化醫療協作。

市場動態：

廠商中立歸檔（VNA）市場的成長受到多種因素的驅動，例如慢性病盛行率上升導致診斷影像量增加、集中式醫學影像儲存系統需求日益成長，以及不同醫療機構間資料共用和患者照護協調的改善需求。然而，實施和維護VNA的高成本，以及專業技術（尤其是在小規模醫療機構）的缺乏，阻礙了VNA的廣泛應用。另一方面，遠端醫療實踐的擴展、人工智慧（AI）和預測分析等技術的進步，為供應商創造了盈利的市場機會。

本報告的主要特點

本報告揭示了各個細分市場的潛在商機，並描述了該市場中一系列有吸引力的投資提案。
此外，它還提供了有關市場促進因素和限制因素、機會、新產品發布和批准、市場趨勢、區域展望以及主要公司採取的競爭策略的重要見解。
本節根據公司概況、產品系列、主要趨勢、財務績效和策略等各種參數，對全球廠商中立歸檔 (VNA) 市場的主要公司進行介紹。
本報告中的見解將使負責人和企業經營團隊能夠就未來的產品發布、技術更新、市場擴張和行銷策略做出明智的決策。
《全球供應商中立歸檔 (VNA) 市場》報告面向該行業的眾多相關人員，包括投資者、供應商、產品製造商、經銷商、新進業者和金融分析師。
相關人員可以透過分析全球供應商中立歸檔 (VNA) 市場中使用的各種策略矩陣來促進決策。

北美洲
- 美國
- 加拿大
歐洲
- 德國
- 英國
- 西班牙
- 法國
- 義大利
- 俄羅斯
- 其他歐洲國家
亞太地區
- 中國
- 印度
- 日本
- 澳洲
- 韓國
- ASEAN
- 其他亞太國家
拉丁美洲
- 巴西
- 阿根廷
- 墨西哥
- 其他拉丁美洲國家
中東
- 海灣合作理事會國家
- 以色列
- 其他中東國家
非洲
- 北非
- 中非
- 南非

第9章競爭情勢

Johnson & Johnson Private Limited
Merck & Co., Inc.
F. Hoffmann-La Roche Ltd.
Baxter
Bayer AG
Eli Lilly and Company
Sun Pharmaceutical Industries Ltd.
Aurobindo Pharma
Lupin
Allergan
AbbVie Inc.
Abbott
Bausch Health Companies Inc.
Pfizer Inc.
GlaxoSmithKline plc
Novartis AG
Mylan NV
Teva Pharmaceutical Industries Ltd.
Sanofi
AstraZeneca

第10章

分析方法
關於 Coherent Market Insights

簡介目錄

Product Code: CMI6654

Global Vendor Neutral Archive (VNA) Market is estimated to be valued at USD 4.18 Bn in 2026 and is expected to reach USD 6.12 Bn by 2033, growing at a compound annual growth rate (CAGR) of 5.6% from 2026 to 2033.

Report Coverage		Report Details
Base Year:	2025	Market Size in 2026:	USD 4.18 Bn
Historical Data for:	2020 To 2024	Forecast Period:	2026 To 2033
Forecast Period 2026 to 2033 CAGR:	5.60%	2033 Value Projection:	USD 6.12 Bn

Vendor neutral archive (VNA) is an image management solution that allows medical images and associated reports to be stored, queried, and retrieved by any healthcare application from multiple sources and modalities. Traditionally, healthcare organizations have had to manage multiple PACS systems to store and access radiology images which led to increased costs and technological complexities. A VNA provides a central repository that consolidates imaging data from all departments, sources, and specialties in a single archive. This facilitates interoperability, universal access, and optimized care collaboration.

Market Dynamics:

The growth of the vendor neutral archive (VNA) market is driven by factors such as rising imaging volumes due to increasing prevalence of chronic diseases, growing preferences for centralized medical imaging storage systems, and need to improve data sharing and enhance patient care coordination across various care delivery settings. However, high costs associated with the deployment and maintenance of VNAs as well as lack of expertise especially in small healthcare facilities limit their widespread adoption. Meanwhile, growing telehealth practices, technological advancements to enable artificial intelligence integration, and predictive analytics present lucrative opportunities for vendors.

Key features of the study:

It elucidates potential revenue growth opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global vendor neutral archive (VNA) market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study include Johnson & Johnson Private Limited, Merck & Co., Inc., F. Hoffmann-La Roche Ltd., Baxter, Bayer AG, Eli Lilly and Company, Sun Pharmaceutical Industries Ltd., Aurobindo Pharma, Lupin , Allergan, AbbVie Inc., Abbott, Bausch Health Companies Inc. , Pfizer Inc., GlaxoSmithKline plc, Novartis AG, Mylan N.V., Teva Pharmaceutical Industries Ltd., Sanofi, and AstraZeneca
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
The global vendor neutral archive (VNA) market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global vendor neutral archive (VNA) market

Detailed Segmentation:

Global Vendor Neutral Archive (VNA) Market, By Deployment Model (Revenue, USD Bn, 2021 - 2033)
On-Premise VNA
Cloud-Based VNA
Global Vendor Neutral Archive (VNA) Market, By Vendor Type (Revenue, USD Bn, 2021 - 2033)
Independent Software Vendors (ISVs)
PACS Vendors
Infrastructure Vendors
Global Vendor Neutral Archive (VNA) Market, By Imaging Type (Revenue, USD Bn, 2021 - 2033)
Radiology VNAs
Cardiology VNAs
Pathology VNAs
Global Vendor Neutral Archive (VNA) Market, By End-User (Revenue, USD Bn, 2021 - 2033)
Hospitals
Diagnostic Imaging Centers
Ambulatory Care Centers
Research and Academic Institutes
Regional Insights (Revenue, USD Bn, 2021 - 2033)
North America
- U.S.
- Canada
Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
Middle East
- GCC Countries
- Israel
- Rest of Middle East
Africa
- South Africa
- North Africa
- Central Africa
Global Vendor Neutral Archive (VNA) Market, Key Players
Johnson & Johnson Private Limited
Merck & Co., Inc.
F.Hoffmann-La Roche Ltd.
Baxter
Bayer AG
Eli Lilly and Company
Sun Pharmaceutical Industries Ltd.
Aurobindo Pharma
Lupin
Allergan
AbbVie Inc.
Abbott
Bausch Health Companies Inc.
Pfizer Inc.
GlaxoSmithKline plc
Novartis AG
Mylan N.V.
Teva Pharmaceutical Industries Ltd.
Sanofi
AstraZeneca

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Global Vendor Neutral Archive (VNA) Market, By Deployment Model
- Global Vendor Neutral Archive (VNA) Market, By Vendor Type
- Global Vendor Neutral Archive (VNA) Market, By Imaging Type
- Global Vendor Neutral Archive (VNA) Market, By End User
- Global Vendor Neutral Archive (VNA) Market, By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Increasing adoption of cloud-based VNA solutions
- Growing adoption of imaging equipment across healthcare facilities
Impact Analysis
Key Highlights
Regulatory Scenario
Service Offering Portfolio
PEST Analysis
PORTER's Analysis
Merger and Acquisition Scenario
Pipeline Analysis

4. Global Vendor Neutral Archive (VNA) Market, By Deployment Model, 2021 - 2033, (US$ Bn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
On-premise VNA
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
Cloud-based VNA
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)

5. Global Vendor Neutral Archive (VNA) Market, By Vendor Type, 2021 - 2033, (US$ Bn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
Independent Software Vendors (ISVs)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
PACS Vendors
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
Infrastructure Vendors
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)

6. Global Vendor Neutral Archive (VNA) Market, By Imaging Type, 2021 - 2033, (US$ Bn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
Radiology VNAs
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
Cardiology VNAs
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
Pathology VNAs
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)

7. Global Vendor Neutral Archive (VNA) Market, By End User, 2021 - 2033, (US$ Bn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
Hospitals
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
Diagnostic Imaging Centers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
Ambulatory Care Centers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
Research and Academic Institutes
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)

8. Global Vendor Neutral Archive (VNA) Market, By Region, 2021 - 2033, (US$ Bn)

Introduction
- Market Share Analysis, By Region, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, For Region, 2021 - 2033
- Country Trends
North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Deployment Model, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Vendor Type, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Imaging Type, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033,(US$ Bn)
  - U.S.
  - Canada
Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Deployment Model, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Vendor Type, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Imaging Type, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033,(US$ Bn)
  - Germany
  - U.K.
  - Spain
  - France
  - Italy
  - Russia
  - Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Deployment Model, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Vendor Type, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Imaging Type, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033,(US$ Bn)
  - China
  - India
  - Japan
  - Australia
  - South Korea
  - ASEAN
  - Rest of Asia Pacific
Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Deployment Model, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Vendor Type, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Imaging Type, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033,(US$ Bn)
  - Brazil
  - Argentina
  - Mexico
  - Rest of Latin America
Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Deployment Model, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Vendor Type, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Imaging Type, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033,(US$ Bn)
  - GCC Countries
  - Israel
  - Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Deployment Model, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Vendor Type, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Imaging Type, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Sub-region, 2021 - 2033,(US$ Bn)
  - North Africa
  - Central Africa
  - South Africa

9. Competitive Landscape

Johnson & Johnson Private Limited
- Company Highlights
- Deployment Model Portfolio
- Key Highlights
- Financial Performance
- Strategies
Merck & Co., Inc.
- Company Highlights
- Deployment Model Portfolio
- Key Highlights
- Financial Performance
- Strategies
F. Hoffmann-La Roche Ltd.
- Company Highlights
- Deployment Model Portfolio
- Key Highlights
- Financial Performance
- Strategies
Baxter
- Company Highlights
- Deployment Model Portfolio
- Key Highlights
- Financial Performance
- Strategies
Bayer AG
- Company Highlights
- Deployment Model Portfolio
- Key Highlights
- Financial Performance
- Strategies
Eli Lilly and Company
- Company Highlights
- Deployment Model Portfolio
- Key Highlights
- Financial Performance
- Strategies
Sun Pharmaceutical Industries Ltd.
- Company Highlights
- Deployment Model Portfolio
- Key Highlights
- Financial Performance
- Strategies
Aurobindo Pharma
- Company Highlights
- Deployment Model Portfolio
- Key Highlights
- Financial Performance
- Strategies
Lupin
- Company Highlights
- Deployment Model Portfolio
- Key Highlights
- Financial Performance
- Strategies
Allergan
- Company Highlights
- Deployment Model Portfolio
- Key Highlights
- Financial Performance
- Strategies
AbbVie Inc.
- Company Highlights
- Deployment Model Portfolio
- Key Highlights
- Financial Performance
- Strategies
Abbott
- Company Highlights
- Deployment Model Portfolio
- Key Highlights
- Financial Performance
- Strategies
Bausch Health Companies Inc.
- Company Highlights
- Deployment Model Portfolio
- Key Highlights
- Financial Performance
- Strategies
Pfizer Inc.
- Company Highlights
- Deployment Model Portfolio
- Key Highlights
- Financial Performance
- Strategies
GlaxoSmithKline plc
- Company Highlights
- Deployment Model Portfolio
- Key Highlights
- Financial Performance
- Strategies
Novartis AG
- Company Highlights
- Deployment Model Portfolio
- Key Highlights
- Financial Performance
- Strategies
Mylan N.V.
- Company Highlights
- Deployment Model Portfolio
- Key Highlights
- Financial Performance
- Strategies
Teva Pharmaceutical Industries Ltd.
- Company Highlights
- Deployment Model Portfolio
- Key Highlights
- Financial Performance
- Strategies
Sanofi
- Company Highlights
- Deployment Model Portfolio
- Key Highlights
- Financial Performance
- Strategies
AstraZeneca
- Company Highlights
- Deployment Model Portfolio
- Key Highlights
- Financial Performance
- Strategies
Analyst Views